Ironwood Pharmaceuticals Inc. planned insider sales
In the last twelve months insiders at Ironwood Pharmaceuticals Inc. filed 10 Form 144 notices of planned sales, 560,095 shares worth $2.5 million at the time of filing, from 7 sellers. The latest, filed 23 September 2026: Shetzline Michael (former officer), 83,306 shares worth $377,376, planned for around 24 September 2026 through E Trade Securities LLC.
| Filed | Seller | Relationship | Shares | Value | Planned sale | Sold, per Form 4 | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 23 September 2026 | Shetzline Michael | Former Officer | 83,306 | $377,376 | 24 September 2026 | None on Form 4 yet | E Trade Securities LLC | Restricted Stock Unit award granted pursuant to the Issuer's 2019 Equity Incentive Plan; Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan | Form 144 |
| 7 July 2026 | Ronald Silver | Officer | 127,890 | $560,158 | 7 July 2026 | 127,890 shares from 7 July 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Employee Stock Purchase Plan; Restricted Stock Units | Form 144 |
| 16 June 2026 | Julie McHugh | Director | 21,571 | $79,597 | 16 June 2026 | 21,571 shares from 16 June 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted Stock Units | Form 144 |
| 20 February 2026 | Gaskins Tammi L | Officer | 19,775 | $91,163 | 23 February 2026 | 21,526 shares from 23 February 2026 | E Trade Securities LLC | Restricted Stock Unit award granted pursuant to the Issuer's 2019 Equity Incentive Plan, subject to vesting requirements; Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan, subject to vesting requirements | Form 144 |
| 20 February 2026 | Martini Gregory S. | Officer | 20,163 | $92,951 | 23 February 2026 | 21,944 shares from 23 February 2026 | E Trade Securities LLC | Restricted Stock Unit award granted pursuant to the Issuer's 2019 Equity Incentive Plan, subject to vesting requirements; Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan, subject to vesting requirements | Form 144 |
| 20 February 2026 | Shetzline Michael | Officer | 29,937 | $138,010 | 23 February 2026 | 32,582 shares from 23 February 2026 | E Trade Securities LLC | Restricted Stock Unit award granted pursuant to the Issuer's 2019 Equity Incentive Plan, subject to vesting requirements; Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan, subject to vesting requirements | Form 144 |
| 20 February 2026 | John Minardo | Officer | 33,528 | $154,564 | 23 February 2026 | 36,492 shares from 23 February 2026 | E Trade Securities LLC | Restricted Stock Unit award granted pursuant to the Issuer's 2019 Equity Incentive Plan, subject to vesting requirements; Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan, subject to vesting requirements | Form 144 |
| 20 February 2026 | MCCOURT Thomas A | Officer, Director | 182,185 | $839,873 | 23 February 2026 | 198,283 shares from 23 February 2026 | E Trade Securities LLC | Restricted Stock Unit award granted pursuant to the Issuer's 2019 Equity Incentive Plan, subject to vesting requirements; Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan, subject to vesting requirements | Form 144 |
| 5 January 2026 | Ronald Silver | Officer | 35,416 | $151,226 | 5 January 2026 | 59,589 shares from 5 January 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Employee Stock Purchase Plan | Form 144 |
| 14 November 2025 | Gaskins Tammi L | Officer | 6,324 | $21,312 | 17 November 2025 | 6,016 shares from 17 November 2025 | E Trade Securities LLC | Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan, subject to vesting requirements | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.